Megastigmane derivative compositions and methods for taste modulation

US2024000119A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024000119-A1
Application numberUS-202118253630-A
CountryUS
Kind codeA1
Filing dateDec 15, 2021
Priority dateNov 25, 2020
Publication dateJan 4, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The use of a megastigmane derivative to enhance the sweetness of a sweetness modifier and to decrease the amount of a sweetness modifier used in a consumable is provided.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of enhancing the sweetness of a sweetness modifier comprising the step of adding to the sweetness modifier an olfactory effective amount of a megastigmane derivative of Formula I: wherein one of R 1 and R 2 represents hydrogen and the other one thereof represents a sugar moiety; R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of hydrogen, a methyl group and a hydroxy group, or R 4 and R together form a group —O—; and wherein a dashed line represents an optional carbon-carbon double bond, with the proviso that the dashed line between carbon atom 2 and carbon atom 3 and the dashed line between carbon atom 3 and carbon atom 4 do not simultaneously represent a carbon-carbon double bond; and with the further proviso that when the dashed line between carbon atom 1 and oxygen represents a carbon-carbon double bond, R 1 is absent, when the dashed line between carbon atom 2 and carbon atom 3 represents a carbon-carbon double bond, R 4 is absent, and when the dashed line between carbon atom 3 and carbon atom 4 represents a carbon-carbon double bond, R 4 and R 5 are absent. 2 . The method of claim 1 , wherein the megastigmane derivative having Formula II: wherein R 1′ represents hydrogen and R 2′ represents a sugar moiety; R 3′ , R 4′ , R 5′ , R 5′ and R 7′ are independently selected from the group consisting of hydrogen, a methyl group and a hydroxy group; and wherein a dashed line represents an optional carbon-carbon double bond, with the proviso that the dashed line between carbon atom 2 and carbon atom 3 and the dashed line between carbon atom 3 and carbon atom 4 do not simultaneously represent a carbon-carbon double bond; and with the further proviso that when the dashed line between carbon atom 1 and oxygen represents a carbon-carbon double bond, R 1 is absent, when the dashed line between carbon atom 2 and carbon atom 3 represents a carbon-carbon double bond, R 4 is absent, and when the dashed line between carbon atom 3 and carbon atom 4 represents a carbon-carbon double bond, R 4 and R 5 are absent. 3 . The method of claim 2 , wherein the megastigmane derivative is selected from the group consisting of lauroside A, ampelopsisionoside, bridelionoside F, phlomisionoside, actinidioionoside, (3S,5R,6R,7E,9S)-megastigm-7-ene-3,5,6,9-tetrol 3-(β-D-glucopyranoside), stratioside II, 3-hydroxy-5,6-epoxy-β-ionyl-β-D-glucopyranoside, staphylionoside E, plucheoside B, alangionoside D, roseoside and a mixture thereof. 4 . The method of claim 1 , wherein the sweetness modifier is a natural sweetener selected from the group consisting of sucrose, fructose, glucose, high fructose corn syrup, rebaudioside A, stevioside, rebaudioside D, xylose, arabinose, rhamnose, erythritol, xylitol, mannitol, sorbitol, inositol and a combination thereof. 5 . The method of claim 1 , wherein the sweetness modifier is an artificial sweetener selected from the group consisting of aspartame, sucralose, neotame, acesulfame potassium, saccharin and a combination thereof. 6 . The method of claim 1 , wherein the olfactory effective amount is from about 0.1 ppb to about 500 ppm of the sweetness modifier. 7 . The method of claim 1 , wherein the olfactory effective amount is from about 1 ppb to about 100 ppm of the sweetness modifier. 8 . The method of claim 1 , wherein the olfactory effective amount is from about 10 ppb to about 10 ppm of the sweetness modifier. 9 . The method of claim 1 , wherein the megastigmane derivative is provided as a botanical extract of a plant selected from the group consisting of Eriobotrya japonica, Antidesma bunius, Diospyros maritima, Passiflora incarnata Linn., Opuntia humifusa, Persea americana, Laurus nobilis, Garcinia mangostana, Syzygium samarangense, Antidesma pentandrum var. barbatum, Cirsium setosum, Cinnamomum wilsonii, Antidesma ghaesembilla, Vitis quinguangularis Rehd, Annona muricate and Phoenix dactylifera. 10 . The method of claim 1 , wherein the method further comprising the step of adding an olfactory effective amount of a flavoring. 11 . The method of claim 10 , wherein the flavoring is stevia composition. 12 . The method of claim 11 , wherein the olfactory effective amount is from about 1 ppm to about 5000 ppm of the sweetness modifier. 13 . The method of claim 11 , wherein the megastigmane and the stevia composition have a weight ratio of about 1:50-5000. 14 . A composition comprising a sweetness modifier and a sweetness enhancer containing a megastigmane derivative. 15 . The composition of claim 14 , wherein the sweetness enhancer further comprising a stevia composition. 16 . The composition of claim 14 , wherein the sweetness modifier is a natural sweetener selected from the group consisting of sucrose, fructose, glucose, high fructose corn syrup, rebaudioside A, stevioside, rebaudioside D, xylose, arabinose, rhamnose, erythritol, xylitol, mannitol, sorbitol, inositol and a combination thereof. 17 . The composition of claim 14 , wherein the sweetness modifier is an artificial sweetener selected from the group consisting of aspartame, sucralose, neotame, acesulfame potassium, saccharin and a combination thereof. 18 . The composition of claim 14 , wherein the megastigmane derivative is selected from the group consisting of lauroside A, ampelopsisionoside, bridelionoside F, phlomisionoside, actinidioionoside, (3S,5R,6R,7E,9S)-megastigm-7-ene-3,5,6,9-tetrol 3-(β-D-glucopyranoside), stratioside II, 3-hydroxy-5,6-epoxy-β-ionyl-β-D-glucopyranoside, staphylionoside E, plucheoside B, alangionoside D, roseoside and a mixture thereof. 19 . The composition of claim 15 , wherein the megastigmane and the stevia composition have a weight ratio of about 1:50-5000. 20 . A consumable comprising a sweetness modifier and a sweetness enhancer containing a megastigmane derivative and a stevia composition, wherein the megastigmane and the stevia composition have a weight ratio of about 1:50-5000.

Assignees

Inventors

Classifications

  • A23L27/34Primary

    Sugar alcohols · CPC title

  • Natural spices, flavouring agents or condiments; Extracts thereof · CPC title

  • Taste or flavour enhancing agents · CPC title

  • A23L27/33Primary

    containing sugars or derivatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024000119A1 cover?
The use of a megastigmane derivative to enhance the sweetness of a sweetness modifier and to decrease the amount of a sweetness modifier used in a consumable is provided.
Who is the assignee on this patent?
Int Flavors & Fragrances Inc
What technology area does this patent fall under?
Primary CPC classification A23L27/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).